Curcumin as a Modulator of P-Glycoprotein in Cancer: Challenges and Perspectives

Pharmaceuticals - Switzerland
doi 10.3390/ph9040071
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

GF120918, a P-Glycoprotein Modulator, Increases the Concentration of Unbound Amprenavir in the Central Nervous System in Rats

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2002English

Alkyl-Lysophospholipid Resistance in Multidrug-Resistant Leishmania Tropica and Chemosensitization by a Novel P-Glycoprotein-Like Transporter Modulator

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

P-Glycoprotein Expression in Treated and Untreated Human Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

New Perspectives on Vasoactive Intestinal Polypeptide as a Widespread Modulator of Social Behavior

Current Opinion in Behavioral Sciences
PsychiatryMental HealthBehavioral NeuroscienceCognitive Neuroscience
2015English

Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2011English

Methods of Identification of Drugs as P-Glycoprotein Substrates

I.P.Pavlov Russian Medical Biological Herald
2015English

Biomacromolecules as Tools and Objects in Nanometrology—current Challenges and Perspectives

Analytical and Bioanalytical Chemistry
BiochemistryAnalytical Chemistry
2017English

Vitamin C as a Modulator of the Response to Cancer Therapy

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2019English

The Chaperone TRAP1 as a Modulator of the Mitochondrial Adaptations in Cancer Cells

Frontiers in Oncology
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy